Skip to main content
Pfizer Inc. (SWX:PFE)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
20.92
0.00 (0.00%)
Last updated: Apr 24, 2026, 9:00 AM CET

Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of CHF 118.88 billion. The enterprise value is 161.77 billion.

Market Cap 118.88B
Enterprise Value 161.77B

Important Dates

The next confirmed earnings date is Tuesday, May 5, 2026.

Earnings Date May 5, 2026
Ex-Dividend Date Jan 23, 2026

Share Statistics

Current Share Class 5.69B
Shares Outstanding n/a
Shares Change (YoY) +0.23%
Shares Change (QoQ) -0.49%
Owned by Insiders (%) 0.03%
Owned by Institutions (%) 66.75%
Float 5.68B

Valuation Ratios

The trailing PE ratio is 19.29.

PE Ratio 19.29
Forward PE n/a
PS Ratio 2.40
PB Ratio 1.73
P/TBV Ratio n/a
P/FCF Ratio 16.52
P/OCF Ratio 12.81
PEG Ratio n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.69, with an EV/FCF ratio of 22.48.

EV / Earnings 26.25
EV / Sales 3.28
EV / EBITDA 7.69
EV / EBIT 10.70
EV / FCF 22.48

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.78.

Current Ratio 1.16
Quick Ratio 0.80
Debt / Equity 0.78
Debt / EBITDA 2.54
Debt / FCF 7.45
Interest Coverage 7.17

Financial Efficiency

Return on equity (ROE) is 8.89% and return on invested capital (ROIC) is 13.65%.

Return on Equity (ROE) 8.89%
Return on Assets (ROA) 5.68%
Return on Invested Capital (ROIC) 13.65%
Return on Capital Employed (ROCE) 11.20%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 661,627
Profits Per Employee 82,160
Employee Count 75,000
Asset Turnover 0.30
Inventory Turnover 1.41

Taxes

Income Tax -210.92M
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 21.32
200-Day Moving Average n/a
Relative Strength Index (RSI) 41.27
Average Volume (20 Days) 37

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 3.24

Income Statement

In the last 12 months, Pfizer had revenue of CHF 49.62 billion and earned 6.16 billion in profits. Earnings per share was 1.08.

Revenue 49.62B
Gross Profit 37.62B
Operating Income 15.20B
Pretax Income 5.96B
Net Income 6.16B
EBITDA 20.39B
EBIT 15.20B
Earnings Per Share (EPS) 1.08

Balance Sheet

The company has 10.78 billion in cash and 53.64 billion in debt, giving a net cash position of -42.86 billion.

Cash & Cash Equivalents 10.78B
Total Debt 53.64B
Net Cash -42.86B
Net Cash Per Share n/a
Equity (Book Value) 68.81B
Book Value Per Share 12.06
Working Capital 4.69B

Cash Flow

In the last 12 months, operating cash flow was 9.28 billion and capital expenditures -2.08 billion, giving a free cash flow of 7.20 billion.

Operating Cash Flow 9.28B
Capital Expenditures -2.08B
Depreciation & Amortization 5.17B
Net Borrowing -58.39M
Free Cash Flow 7.20B
FCF Per Share n/a

Margins

Gross margin is 75.81%, with operating and profit margins of 30.62% and 12.42%.

Gross Margin 75.81%
Operating Margin 30.62%
Pretax Margin 12.02%
Profit Margin 12.42%
EBITDA Margin 41.10%
EBIT Margin 30.62%
FCF Margin 14.50%

Dividends & Yields

This stock pays an annual dividend of 1.63, which amounts to a dividend yield of 7.79%.

Dividend Per Share 1.63
Dividend Yield 7.79%
Dividend Growth (YoY) 279.04%
Years of Dividend Growth 1
Payout Ratio 125.74%
Buyback Yield -0.23%
Shareholder Yield 7.56%
Earnings Yield 5.18%
FCF Yield 6.05%
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Pfizer has an Altman Z-Score of 2.11 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.11
Piotroski F-Score 6